THC1 Stock Overview
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Tenet Healthcare Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$87.50 |
| 52 Week High | US$98.00 |
| 52 Week Low | US$49.40 |
| Beta | 2.14 |
| 1 Month Change | -7.89% |
| 3 Month Change | 17.45% |
| 1 Year Change | 40.00% |
| 3 Year Change | 90.59% |
| 5 Year Change | 306.41% |
| Change since IPO | -17.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| THC1 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -6.9% | 3.7% | -2.0% |
| 1Y | 40.0% | -3.9% | -0.3% |
Return vs Industry: THC1 exceeded the German Healthcare industry which returned -3.9% over the past year.
Return vs Market: THC1 exceeded the German Market which returned -0.3% over the past year.
Price Volatility
| THC1 volatility | |
|---|---|
| THC1 Average Weekly Movement | 4.8% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: THC1 has not had significant price volatility in the past 3 months.
Volatility Over Time: THC1's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 92,655 | Saum Sutaria | www.tenethealth.com |
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Tenet Healthcare Corporation Fundamentals Summary
| THC1 fundamental statistics | |
|---|---|
| Market cap | €8.68b |
| Earnings (TTM) | €573.61m |
| Revenue (TTM) | €19.29b |
15.4x
P/E Ratio0.5x
P/S RatioIs THC1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THC1 income statement (TTM) | |
|---|---|
| Revenue | US$20.55b |
| Cost of Revenue | US$12.74b |
| Gross Profit | US$7.81b |
| Other Expenses | US$7.19b |
| Earnings | US$611.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 6.16 |
| Gross Margin | 37.98% |
| Net Profit Margin | 2.97% |
| Debt/Equity Ratio | 268.7% |
How did THC1 perform over the long term?
See historical performance and comparison